It is the simple fact that HTLV-l1I1 is a retrovirus which is not oncogenic, but is cytopathic and highly replicative in vivo, which makes the future of all human societies on earth beyond the next few years so precarious. Life-long persistence of a retrovirus in its host (which is the way of life of all retroviruses) which is also highly replicative in vivo (which is very unusual for any retrovirus) is characterized by frequent changes in the envelope glycoprotein of infectious virions via mutation, genetic recombination or, rarely, phenotypic mixing. Not only do these envelope changes enable replicative retroviruses to escape the immune mechanisms by antigenic drift within each individual host, it makes the production of an effective vaccine theoretically impossible. Furthermore, a major change in envelope glycoprotein (antigenic shift) can have drastic effects on a retrovirus's biological functions, enabling it to use different host cell receptors, replicate in different cells, or even infect new host species.
During the 10 months which elapsed between the presentation of the papers at the symposium in Utah and their publication, restriction enzyme mapping of the nucleotide sequences of HTLV-111 carried out in several laboratories and recently published have, not surprisingly, confirmed that there are huge differences between the molecular structure of one virus and another. The tiny number of different isolates of HTLV-I 11 which have so far been characterized already comprise a spectrum ranging from closely to distantly related viruses.
At present HTLV-l 11 is transmitted much like HBV and consequently it will spread inexorably through the population of the Third World even without homosexual anal intercourse, intravenous drug abuse, clotting factor or blood transfusions speeding it on its way. In the crowded squalor in which the majority of mankind lives, 'intimate contact' -as contributing scientists in this book coyly call sexual intercourseis entirely superfluous to the slow but steady spread of any persistent cell-free viraemic disease.
Many scientists have asserted that HTLV-l11, unlike HBV, is also transmitted to women by infected men merely by heterosexual vaginal intercourse, but the evidence supporting this hypothesis is tenuous. Nevertheless HTLV-l1I1 has already been isolated from mononuclear cells in semen and saliva of asymptomatic carriers. The antigenic drift and shift which has already produced innumerable antigenic strains of HTLV-1 11 may at any time allow the development of strains which can use the receptors of cervical, urethral, buccal or respiratory mucosal cells for attachment and replication within them, thereby enabling transmission to occur not only like HBV but also by the respiratory and oral routes. With such a prolonged asymptomatic incubation period, several years will elapse before strains using new transmission routes will surface as patients with AIDS.
The retrovirus which causes maedi-visna in sheep, is one of the very few non-oncogenic retroviruses known to cause disease in any animal. Like HTLV-111 it is a member of the subfamily Lentivirinae and causes a classic slow virus disease. It has evolved to be transmitted either by respiratory aerosols, saliva, mother's milk or faeces. Infection produces a 100% mortality after an asymptomatic incubation period of 2 to 8 years without the virus even being cytopathic to the peripheral blood leukocytes which it persistently infects, and in which it replicates quite slowly compared with HTLV-1 11.
The editors, in the one-page preface which is all that ties together the 30 diverse papers delivered at the symposium, used two and a half precious lines to inform the world that 'The cost of travel and subsistence for invited speakers and discussants was borne by Schering, as was the cost of refreshments during nightly mixers held to promote discussion'.
Nero fiddled while Rome burned, but at least he knew it was burning. Did not even one of the molecular biologists, imbibing ideas along with their free 'refreshments', realize that the subject matter of their symposium was the molecular biological equivalent of nuclear war against man; and that the tiny finger of HTLV-l1, not that of the resident incumbent in the White House or Kremlin, had already pressed the molecular button? JOHN Krauer is Professor of Obstetrics and Gynaecology in Geneva; and Frank Hytten is the leading expert in human maternal physiology in pregnancy.
The book does not pretend to be a handbook of which drugs to prescribe in pregnancy. However, the authors do give a superb account of the factors which influence pharmacokinetics in pregnancy, followed by detailed information (where available) on the pharmacokinetics of all drugs that are likely to be used in pregnancy. Such information has not been available in one text before. The book should be available to all clinical pharmacologists, academic obstetricians and those interested in the physiology and medical problems of pregnancy. It is highly recommended and excellent value. MICHAEL The style is set by Professor Kaback, who reviews the burden caused by the kind of genetic and part-genetic conditions that are the object of prenatal diagnosis. He stresses that nearly 19 out of every 20 prenatal investigations for serious risk of abnormality show that the fetus in question is normal, so that not all news is bad. Far from it ... He also stresses that prenatal diagnosis cannot be universally applied, is strictly anomalyspecific, and that it must be seen in the context of expert genetic counselling, whose object is to look at all preventive options, not just prenatal diagnosis. The obstetric methods, as well as some of the laboratory techniques, are discussed, and the principles underlying the newer DNA analyses are clearly outlined. Chorionic villi sampling for first trimester diagnosis is briefly taken on, but by now experience of this field has moved considerably, though many problems, both technical and interpretational, still have to be solved. Excellent ultrasonic facilities before the biopsy allow appropriate selection of fetuses, and improve the outcome of the technique, by avoiding dead or dying conceptuses.
Of the many indications for prenatal diagnosis, the risk of chromosome anomalies is clearly spelled out. The sixty or so inborn errors diagnosable by 'enzyme-protein' studies are listed. The haemoglobinopathies are a clear example of the application of DNA technology to diagnosis, but, quite rightly, the limitations of DNA probes in some disorders, and the difficulties that may relate to the use of DNA studies which exploit linkage and often require family investigation are stressed. The success story of the prenatal diagnosis of neural tube defects in 'at risk' families, or of population screening, and the use of chemical and ultrasound techniques are all well covered. The vista of primary prevention (in this country) is also discussed. Ultrasound in the prenatal detection of congenital cardiovascular disease is emphasized: in 1000 high risk pregnancies, 26 abnormalities were predicted, 4 minor ones overlooked, and normality accurately assessed in the rest. The hard problems of the relatively common Duchennetype muscular dystrophy and cystic fibrosis (both childhood lethals) are still looking for a solution. A variety of other indications (fetal genetic skin diseases, genetic bone dysplasias, DNA repair defects, etc) are briefly presented. Fetal therapy and its future are outlined, and, finally, the social impact and implications of this relatively new area of diagnostic medicine are considered.
Altogether, an excellent volume, which gives good coverage of a field which is still moving rapidly in the direction of new techniques, new applications, greater accuracy of old methods, and earlier diagnosisthe last-named in particular being an especially desirable goal. PAUL Digestive Surgery emerged in August 1984 as the latest journal to vie for space and funding on our already crowded and costly library shelves. It will be published four times annually in English and is intended as a forum where surgeons with a special interest in the digestive tract can communicate with colleagues from their own and related fields. The journal will cover clinical and experimental research in digestive surgery, but also aims to embrace relevant work from the basic sciences and other clinical specialties which may influence progress in the surgery of the alimentary tract. The aims are laudable and the Editors in Chief (E H Farthmann, Freiburg, FRG; L F Hollender, Strasbourg, France) are backed by a suitably heavyweight international editorial board of 10 well-known surgeons. No doubt there are more papers seeking publication than there are spaces in the established main-line surgical journals. How-
